Ribociclib (LEE011)
-
Catalog number9481-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_name7-cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide
-
DescriptionRibociclib is a potent cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. LEE011 has been shown to reduce proliferation in 12 of 17 human neuroblastoma-derived cell lines by inducing cytostasis (mean IC₅₀ = 306 nM in sensitive lines).
-
CAS Number1211441-98-3
-
Structure AvailableYes
-
Molecular FormulaC₂₃H₃₀N₈O
-
Molecular Weight434.54
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (~10 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent cyclin-dependent kinase (CDK) inhibitor
-
Storage Condition-20°C
-
Shipping ConditionGel pack
-
Shelf Life36 months
-
PubChem CID44631912
-
SMILESCN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5
-
InChiInChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28)
-
InChi KeyRHXHGRAEPCAFML-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameRibociclib (LEE011)
-
Alternative nameRibociclib (LEE011)
-